Parotid gland metastases of distant primary tumours: A diagnostic challenge

Franzen, Achim; Günzel, Thomas; Lieder, Anja

doi:10.1016/j.anl.2015.09.010

Cited by 24 publications

(30 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Malignancy rate for the parotid gland tumor is 0.2 [3,4]. SNPs havean average incidence of 6-8% of all parotid gland tumors, metastases originate from head and neck malignancies commonly and distant metastases rarely [5,6]. As a rare entity, there are few series of SNP and the literature mostly arises from the case reports.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prophylactic and therapeutic parotidectomy for secondary neoplasms of the parotid gland

Ant

Toprak

Kılıç

et al. 2020

The European Research Journal

View full text Add to dashboard Cite

Objectives: The aim of this study was to review the demographic and clinicopathological findings of the patients who underwent prophylactic or therapeutic parotidectomy due to the secondary neoplasm of the parotid gland (SNP), the outcomes of the patients with SNP and to provide a perspective to the parotid and neck approach in head and neck skin cancer cases. Methods: The clinical data of 178 patients who underwent parotidectomydue to neoplasm in the Department of Otorhinolaryngology, Head and Neck Surgery of a tertiary referral center from 2012 to 2017 were reviewed. Results: Among 178 patients, twenty-two (12.4%) patients were found to underwentprophylactic or therapeutic parotidectomy due to SNP. Six of these patients had pathologically positive parotid metastases (therapeutic parotidectomy). The median age of six patients was 67 years (ranging from 2 to 83 years). Five patients were male and one was female. The most common indication of parotidectomy (prophylactic and therapeutic) and pathology of parotid mass due to SNP and Cutaneous Squamous Cell Carcinoma (SCC) (36.3% and 50%, respectively). Conclusions: Owing to rapidly progressive feature and high morbidity, close observation of parotid in case of metastasis is crucial for recurrent SCC of the face and scalp.

show abstract

Section: Discussionmentioning

confidence: 99%

“…! "#$%&M(&O501-0.+,2&5,.P&B"2+05.&0B&C-4".,4%&DA+"-%0A.&EFA"70A.&D%$$&D"52,-07"&#".%6& 0-&9GDD&@H'I&J'HK& SCC of the oral cavity and oropharynx were also reported as the primary sites of the parotid metastases [4,5,25,26]. Increased number of cancer-positive lymph nodes were reported to increase the risk of parotid involvement by Harada et al [27].…”

mentioning

confidence: 99%

Prophylactic and therapeutic parotidectomy for secondary neoplasms of the parotid gland

Ant

Toprak

Kılıç

et al. 2020

The European Research Journal

View full text Add to dashboard Cite

show abstract

“…The first cases of parotid involvement due to RCC metastases were reported by Patey et al in 1965 7 . Since then, there have been limited reported cases of this phenomenon 6,[8][9][10][11][12][13][14][15][16] . In their review of the literature, Lawlor et al reported 45 cases of RCC metastasizing to the parotid, of which only 31 were complete case presentations 6 .…”

Section: Discussionmentioning

confidence: 99%

Rare case of Clear Cell Renal Cell Carcinoma metastasizing to contralateral kidney and ipsilateral parotid more than five years following nephrectomy

Sydney¹,

Ioakim²,

Kara³

et al. 2019

Balkan J Dent Med

View full text Add to dashboard Cite

Summary Backgroung/Aim: Salivary gland malignancies are rare, with only a fraction due to metastases. We report a rare case of the Clear Cell Renal Cell Carcinoma (CCRCC), a subtype of the Renal Cell Carcinoma (RCC), metastasizing to the parotid gland more than five years following nephrectomy. Case report: A 75-year-old female presented with a unilateral left parotid mass that was growing over the period of 18 months. After clinical and laboratory examinations, the patient underwent left partial superficial parotidectomy with preservation of the facial nerve. The significance of the patient’s history of the CCRCC was pivotal to the histopathological diagnosis of a metastatic CCRCC to the parotid. Conclusions: The unpredictable nature of the RCC results in the need for a long period of follow-up, as well as having a high degree of suspicion of metastasis in a patient presenting with a medical history of the RCC and a parotid mass.

show abstract

“…Supraclavicular tumors metastasize in the parotid region usually through lymphogenous routes or per continuitatem, depending on the localization unlike the infraclavicular tumors which usually spread through haematogenous routes. There are even discussions about metastases in the parotid lymph nodes being an expression of lymphogenous metastases whereas parenchymal metastasis is an indication for haematogenous metastasis (10).…”

Section: Discussionmentioning

confidence: 99%

“…Before considering treatment for patients with parotid cancers, it is very important to make a clear distinction between primary and metastatic disease. Parotid metastases in some cases are the first clinical manifestation of a previously unknown tumor (10). Primary tumors can be treated less offensive, with or without neck dissection or adjuvant radiotherapy whereas metastatic cancers demand radical approach (11).…”

Section: Discussionmentioning

confidence: 99%

Parotid Gland Metastases of Other Primary Tumors - A 10 Year Retrospective Study

Cosic¹,

Tomić²,

Trajković³

et al. 2019

amm

View full text Add to dashboard Cite

Metastatic cancers of the parotid are very rear and hard to diagnose neoplasms. They can be classified into two major groups: tumors with supraclavicular and inflaclavicular primary localization. Squamous cell carcinoma of the skin is the most common histological type found; it is followed by melanoma, Merkel cell carcinoma and adenocarcinoma of the lungs. We analyzed 420 patients that were diagnosed with parotid gland tumors at the department of Maxillofacial surgery, Clinic of Dentistry in Niš, from 2007 to 2017. In 121 patients pathohistological findings showed malignant tumors out of which 21 were metastatic. Radical parotidectomy with adjuvant radiotherapy of the head and neck region was the most common type of treatment. Neck dissection was performed in all of the patients but the extent of it depended on the clinical findings. Lymph nodes were negative for the metastatic disease in only 4 patients. Survival rate is very different among patients ranging from 8 to 138 months.

show abstract

Parotid gland metastases of distant primary tumours: A diagnostic challenge

Cited by 24 publications

References 22 publications

Prophylactic and therapeutic parotidectomy for secondary neoplasms of the parotid gland

Prophylactic and therapeutic parotidectomy for secondary neoplasms of the parotid gland

Rare case of Clear Cell Renal Cell Carcinoma metastasizing to contralateral kidney and ipsilateral parotid more than five years following nephrectomy

Parotid Gland Metastases of Other Primary Tumors - A 10 Year Retrospective Study

Contact Info

Product

Resources

About